U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07076628) titled 'Respiratory Depression of Remimazolam vs. Propofol for Monitored Anesthesia Care' on Feb. 02, 2022.
Brief Summary: The comparison of incidence of respiratory depression between remimazolam and propofol under monitored anesthesia care for hysteroscopic surgery
Study Start Date: Aug. 24, 2023
Study Type: INTERVENTIONAL
Condition:
Propofol
Remimazolam
Hysteroscopic Surgery
Respiratory Insufficiency
Hemodynamics Instability
Intervention:
DRUG: Propofol
Propofol infusion with remifentanil
DRUG: Remimazolam
Remimazolam infusion with remifentanil
Recruitment Status: COMPLETED
Sponsor: DongGuk University
Information provided by ...